AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 13 analysts
Fundamentals
Fundamentals institutional score is 27 using EVA spread proxy -8.4%; growth durability 56.2.
Valuation
Valuation institutional score is 97 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 85 using mean target upside 44.6%; dispersion penalty 13.9; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 64 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
This data source has not been supplied for the decision payload.
Signal Summary
Market intelligence remains Neutral. valuation and analyst consensus provide support, while fundamentals remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 16.7% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.53). Confidence: 89%.
Live forward EPS implies next-12-month EPS of ₹15.61. Applying the stock's normalized valuation corridor produces a fair range of ₹930.04 to ₹1,094.89, with base value near ₹1,012.00 (+123.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹15.61
Forward P/E
29.0x
Base Fair Value
₹1,012.00
Fair Range
₹930.04 - ₹1,094.89
Upside To Base
+123.8%
Estimate Source
Live forward EPS
Growth Estimate
+2.7%
5Y Average
64.04
Current
54.03
Overvalued
70.14
Undervalued
59.58
5Y Average
33.46
Current
28.22
Overvalued
35.86
Undervalued
30.05
5Y Average
3.83
Current
3.23
Overvalued
4.40
Undervalued
3.25
Peers & Comparison
Sector: Consumer Staples · Theme: FMCG - Household Products
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
CELLO WORLD LIMITED CELLOFMCG - Household Products | -0.3% | 14.0% | 26.3x Fair | +8% vs avg | -36.1% |
JYOTHY LABS LIMITED JYOTHYLABFMCG - Household Products | +8.1% | 11.3% | 22.5x Fair | -8% vs avg | -38.3% |
Eureka Forbes Limited trades at a premium (54.0x vs peer avg 24.4x), implying higher growth or quality expectations from the Fmcg - Household Products cohort. Peers include CELLO WORLD LIMITED, JYOTHY LABS LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹684 CrMar 2026Latest net profit
₹51 CrMar 2026Latest EPS
₹2.64Mar 2026Net margin
12.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 508 | 505 | 592 | 539 | 553 | 553 | 673 | 598 | 613 | 608 | 773 | 645 | 684 |
| Expenses + | 461 | 459 | 541 | 496 | 500 | 498 | 601 | 539 | 535 | 546 | 678 | 578 | 599 |
| Operating Profit | 47 | 46 | 51 | 42 | 53 | 55 | 72 | 59 | 78 | 61 | 96 | 67 | 85 |
| OPM % | 9% | 9% | 9% | 8% | 10% | 10% | 11% | 10% | 13% | 10% | 12% | 10% | 12% |
| Other Income + | -5 | 2 | 2 | 3 | -13 | 2 | 6 | 4 | 6 | 7 | 6 | -35 | 5 |
| Interest | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 2 |
| Depreciation | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 15 | 15 | 16 | 16 | 17 | 20 |
| Profit before tax | 26 | 31 | 37 | 30 | 24 | 42 | 62 | 47 | 68 | 52 | 83 | 12 | 68 |
| Tax % | 37% | 29% | 31% | 25% | 12% | 25% | 25% | 26% | 25% | 25% | 26% | 27% | 25% |
| Net Profit + | 16 | 22 | 25 | 23 | 21 | 31 | 47 | 35 | 51 | 39 | 62 | 9 | 51 |
| EPS in Rs | 0.84 | 1.14 | 1.32 | 1.17 | 1.11 | 1.61 | 2.41 | 1.80 | 2.62 | 1.99 | 3.18 | 0.47 | 2.64 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Board Meeting Intimation for Considering And Approving Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026